Yellow Fever Vaccine (YF-V) shortage in the U.S.

Wednesday, September 27, 2017

Currently, there is a Yellow Fever Vaccine (YF-V) shortage in the United States, which may affect travel planning for some Princeton students and scholars. The YF-V will be unavailable until spring 2018, at the earliest.

Yellow fever is an illness transmitted by mosquitoes and is prevalent in tropical areas of South America and Africa.

In order to cover the demand for YF-V in the U.S., a manufacturing company received permission from the FDA to import and circulate another yellow fever vaccine, called Stamaril, as an investigational new drug (IND). Stamaril is the yellow fever vaccine used in Europe and other areas of the world outside the United States. It has a proven safety and efficacy profile similar to the YF-V manufactured in the U.S.

In order to ensure that all University-sponsored travelers receive the vaccination for yellow fever, we advise advanced planning.

Availability of the vaccine

Stamaril is not available at UHS but it is available at travel health clinics around the United States.

Additional questions or assistance with travel planning

If you are planning University-sponsored trips to yellow fever zones, contact Dr. Irini Daskalaki UHS Global and Community Health Physician, to receive more information.